Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample type	Gender
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	249	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	370	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	373	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	148283	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	153370	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	153520	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	155587	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	157333	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	159448	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	162450	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	162494	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	167757	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	171661	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	175210	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	176225	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	177033	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	177231	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	178719	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	181178	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	187559	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	188592	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	189697	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	190233	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	192467	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	194009	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	194311	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	195132	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	200202	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	200568	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	202272	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	205008	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	206612	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	206668	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	206959	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	207172	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	207629	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	208372	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	209373	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	210793	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	211922	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	212592	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	213746	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	213921	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	214218	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	214494	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	214938	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	215046	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	215705	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	216037	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	216422	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	217574	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	217610	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	217778	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	218194	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	218999	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	219096	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	219771	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	220216	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	220270	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	220505	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	221883	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	222071	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	222614	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	223904	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	224515	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	225363	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	225756	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	225927	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	227176	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	227933	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	228586	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	228882	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	229106	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	229249	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	230653	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	231072	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	231326	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	231977	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	232900	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	233360	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	233499	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	233771	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	234107	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	234179	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	234702	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	234801	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	234971	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	234988	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	235044	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	235398	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	235485	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	235671	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	236450	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	236711	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	236919	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	236987	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	237222	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	237321	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	237463	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	237614	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	237680	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	237762	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	237910	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	237925	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	238036	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	238116	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	238160	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	238260	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	238407	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	238450	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	238485	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	238647	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	238709	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	238854	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239127	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239134	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239293	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239316	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239349	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239384	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239388	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239395	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239422	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239483	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239796	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239844	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239925	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239944	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	239965	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	240132	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	240399	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	240529	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	240651	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	240698	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	240988	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	241043	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	241052	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	241698	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	241722	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	241771	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	241852	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	242417	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	242452	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	242744	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	242900	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	242967	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	243665	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	243836	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	243845	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	244280	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	244371	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	244717	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	245062	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	245063	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	245449	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	245598	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	245734	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	245859	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	246196	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	246992	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	247152	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	247197	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	248456	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	248751	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	249618	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	249632	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	250008	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	252282	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	252403	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	252860	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	254771	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	255190	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	255362	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	255632	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	255858	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	255889	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	255958	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	256000	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	256940	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	257119	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	257405	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	257581	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	257969	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	258462	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	258510	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	258780	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	259087	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	259117	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	259513	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	259596	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	259828	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	260946	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	262266	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	263400	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	263661	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	264063	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	264225	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	264619	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	264714	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	3-methyl-2-oxovalerate	264744	Peak area normalized	Sample	male

Return to search page